Proteome Sciences (LON:PRM) Stock Passes Above Two Hundred Day Moving Average – Time to Sell?

Proteome Sciences plc (LON:PRM) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1.92 and traded as high as GBX 2. Proteome Sciences shares last traded at GBX 1.51, with a volume of 5,639 shares.

Proteome Sciences Price Performance

The company has a market cap of £5.30 million, a price-to-earnings ratio of -1.45 and a beta of 0.17. The company has a fifty day simple moving average of GBX 1.56 and a two-hundred day simple moving average of GBX 1.92. The company has a quick ratio of 0.37, a current ratio of 0.13 and a debt-to-equity ratio of -165.46.

Proteome Sciences (LON:PRM) last released its quarterly earnings results on Wednesday, April 15th. The company reported GBX (1.04) earnings per share (EPS) for the quarter. The firm had revenue of GBX 376 million for the quarter. Proteome Sciences had a positive return on equity of 33.80% and a negative net margin of 81.50%.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.